Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Assets (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Return on Assets for 4 consecutive years, with 1.81% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Assets fell 53.0% to 1.81% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.81%, a 53.0% decrease, with the full-year FY2024 number at 1.23%, down 45.0% from a year prior.
  • Return on Assets was 1.81% for Q3 2025 at bioAffinity Technologies, up from 2.27% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.62% in Q4 2022 to a low of 2.27% in Q2 2025.
  • A 4-year average of 1.21% and a median of 1.11% in 2024 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: decreased -17bps in 2024, then tumbled -108bps in 2025.
  • bioAffinity Technologies' Return on Assets stood at 0.62% in 2022, then crashed by -39bps to 0.86% in 2023, then crashed by -60bps to 1.38% in 2024, then plummeted by -31bps to 1.81% in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Return on Assets are 1.81% (Q3 2025), 2.27% (Q2 2025), and 1.61% (Q1 2025).